{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-058495","form_type":"8-K","ticker":"SXTP","cik":"0001946563","company_name":"60 DEGREES PHARMACEUTICALS, INC.","filed_at":"2026-05-18T20:33:00+00:00","discovered_at":"2026-05-18T20:34:00.244234+00:00","generated_at":"2026-05-18T20:44:22.699110+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"60 Degrees Pharmaceuticals appoints Eric Francois to Board of Directors","bullets":["Eric Francois appointed to board effective May 13, 2026; compensation consistent with standard non-employee director arrangements.","Francois brings over 20 years of healthcare and life sciences leadership; currently independent director at CERo Therapeutics (CERO).","Previously CFO of SCYNEXIS (SCYX), raised over $300M through FDA approval and launch; earlier MD in healthcare investment banking at Raymond James and Credit Suisse.","No family relationships or material transactions with company; appointment not pursuant to any arrangement with others."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-058495","json":"https://secwatch.observer/filing/0001213900-26-058495.json","markdown":"https://secwatch.observer/filing/0001213900-26-058495.md","text":"https://secwatch.observer/filing/0001213900-26-058495.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1946563/000121390026058495/0001213900-26-058495-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1946563/000121390026058495/ea0291366-8k_60degrees.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T20:44:22.699110+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7af387d1ab","claim":"Eric Francois was appointed as Member of the Board at 60 DEGREES PHARMACEUTICALS, INC..","evidence_excerpt":"On May 13, 2026, the Board of Directors (the “Board”) of 60 Degrees Pharmaceuticals, Inc. (the “Company”) appointed Eric Francois to serve as a member of the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390026058495/0001213900-26-058495-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Member of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}